Pharmacology, Toxicology and Pharmaceutical Science
Iron Poisoning
85%
Wound Healing
79%
Iron
67%
Deferoxamine
51%
Mouse
51%
Wound
51%
Inflammation
46%
Skin Injury
45%
Deferiprone
43%
Exendin 4
39%
Inflammatory Disease
39%
Bempedoic Acid
39%
Drug Development
39%
Dasatinib
39%
Cerebrovascular Disease
39%
Furin
39%
Pyroxylin
39%
Liver Cell Carcinoma
39%
Ferroptosis
39%
Antiinflammatory Agent
26%
Protein
22%
Thalassemia
21%
Canagliflozin Plus Metformin
19%
Lisinopril
19%
Alogliptin
19%
Anticoagulant Agent
19%
Thrombosis
19%
Malignant Neoplasm
17%
Antioxidant
15%
Fibrosis
13%
Sepsis
13%
Rheumatoid Arthritis
13%
Infection
13%
Antiplatelet
13%
Blood Clotting Factor 9 Concentrate
13%
Bispecific Antibody
13%
Anti-Inflammatory Drug
11%
Inflammation
11%
Scar Formation
11%
Ointment Base
11%
1,1 Diphenyl 2 Picrylhydrazyl
11%
Flavonoid
11%
Phytochemical
11%
Estropipate
11%
IC50
10%
Heart Infarction
9%
Vein Thrombosis
9%
Blood Clotting Factor 11
9%
C57BL 6 Mouse
9%
Cytotoxicity
8%
Medicine and Dentistry
Dasatinib
79%
Therapeutic Procedure
76%
Receptor
59%
Platelet
55%
Skin Injury
49%
Brain Ischemia
49%
Inpatient
47%
Iron Overload
46%
Deferoxamine
39%
Sodium Glucose Cotransporter 2 Inhibitor
39%
Sodium Proton Exchange Protein 1
39%
Artery Thrombosis
39%
Deferiprone
39%
Furin
39%
Drug
39%
Antiplatelet Drug
39%
Blood Stasis
36%
Apoplexy
31%
Clinical Study
25%
Thrombosis
25%
Blood Clotting Factor 8
23%
Angiogenesis
19%
Wound
19%
Transient Ischemic Attack
19%
Injury
19%
Antithrombotic
19%
Antithrombotic Activity
19%
Patient
17%
Bispecific Antibody
15%
Blood Clotting Factor 8 Concentrate
15%
Antiplatelet
15%
Fibrin
14%
Ion Conductance
13%
Chelation Therapy
11%
Thrombocyte Activation
11%
Inflammation
11%
Antibody
11%
Piperazine Estrone Sulfate
11%
Coronary Artery Disease
9%
Artery
9%
Skin
9%
Neutrophil
9%
Antisense Oligonucleotide
9%
Position
9%
Tumor Necrosis Factor
9%
Dimethyl Sulfoxide
9%
Factor XI
9%
Myocardial Infarction
9%
Vein
9%
Degeneration
9%
Immunology and Microbiology
Platelet
100%
Inflammation
61%
Mouse Model
45%
Development
39%
Inflammatory Disorder
39%
Glycoprotein
39%
Alveolar Macrophage
39%
Macrophage
18%
Angiogenesis
15%
Neutrophil Granulocyte
12%
Tumor Necrosis Factor Alpha
12%
Chemokine
9%
Animal
7%
Blood Vessels
7%
Inflammatory Arthritis
5%
Immune Cell Infiltration
5%
Inflammation Response
5%
Inflammatory Bowel Disease
5%
Systemic Inflammation
5%
Peritoneum
5%
Hemostasis
5%
Megakaryocyte
5%
Vasculitis
5%
Cell Surface
5%